Core Viewpoint - CONMED Corporation reported mixed financial results for Q3 2025, with adjusted earnings per share beating estimates but a significant decline in GAAP earnings per share. Revenue growth was driven by strong performance in General Surgery and Orthopedic Surgery product lines, although margins contracted significantly [2][3][4][5][7][8]. Financial Performance - Adjusted earnings per share for Q3 2025 were $1.08, a 2.9% increase year over year, surpassing the Zacks Consensus Estimate by 2.9% [2]. - GAAP earnings per share fell to 9 cents, down 94.3% from $1.57 in the same quarter last year [2]. - Total revenues reached $337.9 million, reflecting a 6.7% year-over-year increase and exceeding estimates by 0.4% [3]. Revenue Breakdown - Orthopedic Surgery revenues were $138.2 million, up 5.9% year over year [4]. - General Surgery revenues totaled $199.7 million, a 7.3% increase year over year [5]. - Domestic revenues were $194 million, up 5.9%, while international revenues were $143.9 million, up 7.8% [6]. Margin Analysis - Gross profit decreased by 7.2% year over year to $166.1 million, with gross margin contracting by 736 basis points to 49.2% [7]. - Selling and administrative expenses rose 40.7% to $140.3 million, while total operating expenses increased 36.1% to $154.2 million [8]. Financial Position - CONMED ended Q3 2025 with a cash balance of $38.9 million, up from $33.9 million at the end of Q2 [9]. - Long-term debt decreased to $853 million from $881.1 million in the previous quarter [9]. - Cumulative net cash from operating activities was $53.7 million, compared to $51.2 million a year ago [9]. Guidance - For 2025, total revenues are now expected to be between $1.365 billion and $1.372 billion, and adjusted earnings per share are projected to be in the range of $4.48 to $4.53 [10]. Market Outlook - Recent estimates for CONMED have shown an upward trend, contributing to a Zacks Rank of 2 (Buy), indicating expectations for above-average returns in the coming months [11][13].
Why Is Conmed (CNMD) Up 0.1% Since Last Earnings Report?